FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 336:1303-1309 May 1, 1997 Number 18 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Acute renal failure that requires renal-replacement therapy is a relatively common condition, with an annual incidence of at least 30 cases per 1 million population.¹ Historically, the replacement of renal function in acute renal failure has involved techniques also employed in the treatment of end-stage chronic renal failure — intermittent hemodialysis and peritoneal dialysis.^2,3 Hemofiltration was first described in 1977 as a means of removing extracellular fluid from patients with edema refractory to diuretic agents.⁴ Continuous hemofiltration, combined with the administration of an appropriate fluid, is now recognized as a form of renal-replacement therapy in acute renal failure. The technique . . . [Full Text of this Article]

Basic Principles

Continuous Arteriovenous Hemofiltration

Continuous Arteriovenous Hemodialysis with Filtration

Continuous Venovenous Hemofiltration

Continuous Venovenous Hemodialysis with Filtration

Practical Aspects of Continuous Venovenous Hemofiltration

Hemofiltration for Acute Renal Failure

Costs of Hemofiltration

Conclusions

Source Information

From St. Thomas' Hospital, London SE1 7EH, United Kingdom, where reprint requests should be addressed to Dr. Hilton.

References

Related Letters:

Continuous Hemofiltration
Hostetter T. H., Manske C. L., Paller M. S., Hsu C.-y., Palsson R., Niles J. L., van Bommel E. F.H., Grootendorst A. F., Forni L.G., Hilton P.J.
Extract | Full Text  
N Engl J Med 1997; 337:712-714, Sep 4, 1997. Correspondence

This article has been cited by other articles:

• Abdul Rauf, A., Hall Long, K., Gajic, O., Anderson, S. S., Swaminathan, L., Albright, R. C. (2008). Intermittent Hemodialysis Versus Continuous Renal Replacement Therapy for Acute Renal Failure in the Intensive Care Unit: An Observational Outcomes Analysis. J Intensive Care Med 23: 195-203 [Abstract]  
• Hall, N. A, Fox, A. J (2006). Renal replacement therapies in critical care. Contin Educ Anaesth Crit Care Pain 6: 197-202 [Full Text]  
• Fry, A C, Farrington, K (2006). Management of acute renal failure. Postgrad. Med. J. 82: 106-116 [Abstract] [Full Text]  
• Ittner, K. P., Roth, G., Gruber, M., Pawlik, M., Taeger, K. (2005). Clearance of moxifloxacin during continuous haemofiltration (CVVHF) in vitro. J Antimicrob Chemother 56: 360-364 [Abstract] [Full Text]  
• Fish, D. N., Teitelbaum, I., Abraham, E. (2005). Pharmacokinetics and Pharmacodynamics of Imipenem during Continuous Renal Replacement Therapy in Critically Ill Patients. Antimicrob. Agents Chemother. 49: 2421-2428 [Abstract] [Full Text]  
• (2004). Evidence-based Colloid Use in the Critically Ill: American Thoracic Society Consensus Statement. Am. J. Respir. Crit. Care Med. 170: 1247-1259 [Full Text]  
• Bapat, V., Sabetai, M., Roxburgh, J., Young, C., Venn, G. (2004). Early and intensive continuous veno-venous hemofiltration for acute renal failure after cardiac surgery. ICVTS 3: 426-430 [Abstract] [Full Text]  
• Robatel, C., Rusca, M., Padoin, C., Marchetti, O., Liaudet, L., Buclin, T. (2004). Disposition of voriconazole during continuous veno-venous haemodiafiltration (CVVHDF) in a single patient. J Antimicrob Chemother 54: 269-270 [Abstract] [Full Text]  
• Robatel, C., Decosterd, L. A., Biollaz, J., Eckert, P., Schaller, M. D., Buclin, T. (2003). Pharmacokinetics and Dosage Adaptation of Meropenem during Continuous Venovenous Hemodiafiltration in Critically Ill Patients. J Clin Pharmacol 43: 1329-1340 [Abstract] [Full Text]  
• Marenzi, G., Marana, I., Lauri, G., Assanelli, E., Grazi, M., Campodonico, J., Trabattoni, D., Fabbiocchi, F., Montorsi, P., Bartorelli, A. L. (2003). The Prevention of Radiocontrast-Agent-Induced Nephropathy by Hemofiltration. NEJM 349: 1333-1340 [Abstract] [Full Text]  
• Esson, M. L., Schrier, R. W. (2002). Diagnosis and Treatment of Acute Tubular Necrosis. ANN INTERN MED 137: 744-752 [Abstract] [Full Text]  
• Malone, R. S., Fish, D. N., Abraham, E., Teitelbaum, I. (2001). Pharmacokinetics of Cefepime during Continuous Renal Replacement Therapy in Critically Ill Patients. Antimicrob. Agents Chemother. 45: 3148-3155 [Abstract] [Full Text]  
• Malone, R. S., Fish, D. N., Abraham, E., Teitelbaum, I. (2001). Pharmacokinetics of Levofloxacin and Ciprofloxacin during Continuous Renal Replacement Therapy in Critically Ill Patients. Antimicrob. Agents Chemother. 45: 2949-2954 [Abstract] [Full Text]  
• Henderson, J H, McKenzie, C A, Hilton, P J, Leach, R M (2001). Continuous venovenous haemofiltration for the treatment of theophylline toxicity. Thorax 56: 242-243 [Abstract] [Full Text]  
• Okada, S., Teramoto, S., Matsuoka, R. (2000). Recovery from Theophylline Toxicity by Continuous Hemodialysis with Filtration. ANN INTERN MED 133: 922-922 [Full Text]  
• MURRAY, P., HALL, J. (2000). Renal Replacement Therapy for Acute Renal Failure. Am. J. Respir. Crit. Care Med. 162: 777-781 [Full Text]  
• SCHORTGEN, F., SOUBRIER, N., DELCLAUX, C., THUONG, M., GIROU, E., BRUN-BUISSON, C., LEMAIRE, F., BROCHARD, L. (2000). Hemodynamic Tolerance of Intermittent Hemodialysis in Critically Ill Patients . Usefulness of Practice Guidelines. Am. J. Respir. Crit. Care Med. 162: 197-202 [Abstract] [Full Text]  
• Kaufman, D. C., Haas, C. E., Spencer, S., Veverbrants, E. (1999). Adjustment of Nutrition Support With Continuous Hemodiafiltration in a Critically Ill Patient. Nutr Clin Pract 14: 120-123 [Abstract]  
• Hostetter, T. H., Manske, C. L., Paller, M. S., Hsu, C.-y., Palsson, R., Niles, J. L., van Bommel, E. F.H., Grootendorst, A. F., Forni, L.G., Hilton, P.J. (1997). Continuous Hemofiltration. NEJM 337: 712-714 [Full Text]